Home > Insider Trading > Filing (0001127602-13-027470)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
875045	Biogen Idec Inc.	BIIB	Biological Products, (No Disgnostic Substances) (2836)	330112644

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1577061	Alfred Sandrock	Biogen Idec Inc. 133 Boston Post Rd. Weston MA 02493	Grp Svp, Chief Medical Officer	No	Yes	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2013-09-16	9,820	$49.65	24,320	No	4	M	Direct
Common Stock	Disposition	2013-09-16	9,820	$240.10	14,500	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	M	Direct
No	4	S	Direct

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Stock Option (Right to Buy)	Disposition	2013-09-16	9,820	$0.00	9,820	$49.65

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
0		2019-02-23	No	4	M	Direct

Footnotes

Exercise/sale pursuant to a trading plan intended to comply with Rule 10b5-1 of the Securities Exchange Act of 1934.
This represents the weighted average price for shares sold at a range between $240.00 (low) and $240.22 (high).
Full information regarding the number of shares sold at each separate price will be provided upon request by the SEC staff, the issuer, or a security holder of the issuer.
The stock options became exercisable in four (4) equal annual installments commencing one year after the grant date of 02/24/09.